Overview

• On June 2, the Hamburg Public Prosecutor's Office indicted two pharmacists and four company executives for alleged heavy bribery and organized billing fraud tied to cancer medications.
• Prosecutors say the accused acquired a district clinic and ran several medical care centers to dominate prescription flows and submit roughly €75 million in improper reimbursement claims to health insurers.
• The indictment lists 340 instances of billing ineligible chemotherapy prescriptions and alleges doctors were bribed in 37 cases to favor Alanta's in-house medications.
• Investigations into 47 physicians suspected of accepting illicit benefits have been split off into a separate proceeding that remains active.
• The Alanta Health Group has rejected the charges, saying it expects to clear the accusations in court as the Hamburg regional court considers opening formal hearings.